Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-05

Clinical Trial Update: HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ? [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated whether iron supplementation after hepatectomy benefits patients with anemia due to hepcidin overexpression and postoperative…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Geneva | Conditions: Anemia, Postoperative Blood Loss | Phase 3 | Status: COMPLETED